Bristol-Myers Squibb

...types of leukemia. Also joining InterMune as vice president of marketing is Erik Harris, who has worked at Genentech, Elan and Bristol-Myers Squibb, and Darren Cline as vice president of managed care and access. Shoemaker, Harris and...

In this article: Europe, Revenue, Food and Drug Administration, United States, and Tax

...people with leukemia can benefit from the drugs, and said that he's serving as a spokesman to raise awareness of all forms of leukemia. Deininger serves as a consultant for Novartis as well as for Bristol-Myers Squibb, the maker of Sprycel.

In this article: Leukemia, Kareem Abdul-Jabbar, Tasigna, Sprycel, Novartis, Bruno Kirby, Chronic myelogenous leukemia, Philadelphia chromosome, and Oregon Health & Science University

...additions to its leadership team: Vice President, Sales - Ms. Terri Shoemaker has held senior commercial leadership positions at Du Pont Pharmaceuticals, Bristol-Myers Squibb, Pharmion and Celgene. Most recently at Pharmion (acquired by...

In this article: Europe, FDA, United States, Genentech, Celgene, SEC, Novartis, and EU

...rheumatoid arthritis, leukemia drug Sprycel and hepatitis B drug Baraclude. The company also launched its newest drug, Onglyza for diabetes, in the U.S. in August. It produced $20 million in sales by the end of September, and shortly after...

In this article: Bristol-Myers, Revenue, Abilify, Bipolar disorder, Baraclude, Sprycel, Plavix, Reyataz, Leukemia, and Cancer

...patent in 2012. Currently Bristol Myers has a Phase III drug for metastic melanoma, Erbitux for colorectal, head and neck cancer, Sprycel for Leukemia, Ixempra for breast cancer and Taxol for breast, lung and ovarian cancer. Sprycel is the...

In this article: Jim Cramer, Pfizer, Bristol Myers, Jarden, Stanley Works, Black & Decker, BHP, 3M, Cancer, and Agnico Eagle Mines